The OMERACT rheumatoid arthritis magnetic resonance imaging (MRI) scoring system: updated recommendations by the OMERACT MRI in arthritis working group

…, CG Peterfy, P Bird, F Gandjbakhch, D Glinatsi… - The Journal of …, 2017 - jrheum.org
Objective. The Outcome Measures in Rheumatology (OMERACT) Rheumatoid Arthritis (RA)
Magnetic Resonance Imaging (MRI) scoring system (RAMRIS), evaluating bone erosion, …

Effect of magnetic resonance imaging vs conventional treat-to-target strategies on disease activity remission and radiographic progression in rheumatoid arthritis: the …

…, B Ejbjerg, ML Hetland, LM Ørnbjerg, D Glinatsi… - Jama, 2019 - jamanetwork.com
Importance Whether using magnetic resonance imaging (MRI) to guide treatment in patients
with rheumatoid arthritis (RA) improves disease activity and slows joint damage progression …

Validation of the OMERACT Psoriatic Arthritis Magnetic Resonance Imaging Score (PsAMRIS) for the hand and foot in a randomized placebo-controlled trial

D Glinatsi, P Bird, F Gandjbakhch, PJ Mease… - The Journal of …, 2015 - jrheum.org
Objective. To assess changes following treatment and the reliability and responsiveness to
change of the Outcome Measures in Rheumatology (OMERACT) Psoriatic Arthritis Magnetic …

The OMERACT MRI in enthesitis initiative: definitions of key pathologies, suggested MRI sequences, and a novel heel enthesitis scoring system

…, SJ Pedersen, MS Stoenoiu, V Foltz, D Glinatsi… - The Journal of …, 2019 - jrheum.org
Objective. To develop and validate an enthesitis magnetic resonance imaging (MRI) scoring
system for spondyloarthritis/psoriatic arthritis, using the heel as model. Methods. Consensus …

Development and validation of an OMERACT MRI whole-body score for inflammation in peripheral joints and entheses in inflammatory arthritis (MRI-WIPE)

…, RG Lambert, WP Maksymowych, D Glinatsi… - The Journal of …, 2019 - jrheum.org
Objective. To develop a whole-body magnetic resonance imaging (MRI) scoring system for
peripheral arthritis and enthesitis. Methods. After consensus on definitions/locations of MRI …

Dose tapering and discontinuation of biological therapy in rheumatoid arthritis patients in routine care–2-year outcomes and predictors

…, S Krabbe, M Østergaard, L Ørnbjerg, D Glinatsi… - …, 2019 - academic.oup.com
Objectives A cohort of routine care RA patients in sustained remission had biological DMARD
(bDMARDs) tapered according to a treatment guideline. We studied: the proportion of …

Development and validation of the OMERACT rheumatoid arthritis magnetic resonance tenosynovitis scoring system in a multireader exercise

D Glinatsi, P Bird, F Gandjbakhch… - The Journal of …, 2017 - jrheum.org
Objective. To develop and validate a magnetic resonance imaging (MRI) tenosynovitis (TS)
score for tendons at the wrist and metacarpophalangeal (MCP) joint levels in patients with …

Magnetic resonance imaging assessed inflammation in the wrist is associated with patient-reported physical impairment, global assessment of disease activity and …

D Glinatsi, JF Baker, ML Hetland… - Annals of the …, 2017 - ard.bmj.com
Objectives To examine whether MRI assessed inflammation and damage in the wrist of
patients with early rheumatoid arthritis (RA) are associated with patient-reported outcomes (PROs…

Validation of the OMERACT magnetic resonance imaging joint space narrowing score for the wrist in a multireader longitudinal trial

D Glinatsi, S Lillegraven, EA Haavardsholm… - The Journal of …, 2015 - jrheum.org
Objective. To assess the intrareader and interreader agreement and sensitivity to change of
the Outcome Measures in Rheumatology (OMERACT) Rheumatoid Arthritis Magnetic …

[HTML][HTML] Head-to-head comparison of aggressive conventional therapy and three biological treatments and comparison of two de-escalation strategies in patients who …

D Glinatsi, MS Heiberg, A Rudin, D Nordström… - Trials, 2017 - Springer
Background New targeted therapies and improved treatment strategies have dramatically
improved the outcomes of patients with rheumatoid arthritis (RA). However, it is unknown …